Boosting Kids' chickenpox protection: second shot study underway
NCT ID NCT07475000
Summary
This study is checking how well a second dose of chickenpox vaccine works and how safe it is for healthy children. It involves 300 kids aged 15 months to 12 years who have already had one chickenpox shot. All children will receive a second dose made by Sinovac, and researchers will measure their immune response and watch for any side effects over 42 days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VARICELLA IMMUNISATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Akdeniz University Health, Research and Application Center (Hospital), Department of Child Health and Diseases, Department of Social Pediatrics
RECRUITINGAkdeniz, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Ankara Bilkent City Hospital, Pediatrics and Pediatric Infectious Diseases Clinic
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Ege University Hospital (Application and Research Center) Department of Child Health and Diseases
NOT_YET_RECRUITINGEge, Turkey (Türkiye)
Contact Email: •••••@•••••
-
Hacettepe University Hospitals, Department of Pediatrics, Department of Social Pediatrics
RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
-
REPUBLIC of TURKEY MINISTRY of HEALTH ANKARA BILKENT CITY HOSPITAL
NOT_YET_RECRUITINGAnkara, Turkey (Türkiye)
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.